0001567619-18-007116.txt : 20181129
0001567619-18-007116.hdr.sgml : 20181129
20181129164125
ACCESSION NUMBER: 0001567619-18-007116
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181127
FILED AS OF DATE: 20181129
DATE AS OF CHANGE: 20181129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bailey Sue
CENTRAL INDEX KEY: 0001403769
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 181208897
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DRIVE
STREET 2: SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
doc1.xml
FORM 4
X0306
4
2018-11-27
0
0001367644
Emergent BioSolutions Inc.
EBS
0001403769
Bailey Sue
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
1
0
0
0
Common Stock
2018-11-27
4
M
0
8244
18.64
A
57216
D
Common Stock
2018-11-27
4
S
0
8244
69.6197
D
48972
D
Common Stock
2018-11-27
4
M
0
1579
20.08
A
50551
D
Common Stock
2018-11-27
4
S
0
1579
69.6197
D
48972
D
Common Stock
2018-11-27
4
M
0
4736
13.00
A
53708
D
Common Stock
2018-11-27
4
S
0
4736
69.6197
D
48972
D
Common Stock
2018-11-27
4
M
0
3158
13.37
A
52130
D
Common Stock
2018-11-27
4
S
0
3158
69.6197
D
48972
D
Stock Option (Right to buy)
18.64
2018-11-27
4
M
0
8244
0
D
2021-05-21
Common Stock
8244
0
D
Stock Option (Right to buy)
20.08
2018-11-27
4
M
0
1579
0
D
2021-05-18
Common Stock
1579
0
D
Stock Option (Right to buy)
13.00
2018-11-27
4
M
0
4736
0
D
2020-05-22
Common Stock
4736
0
D
Stock Option (Right to buy)
13.37
2018-11-27
4
M
0
3158
0
D
2019-05-16
Common Stock
3158
0
D
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.50 to $70.05, inclusive.
Consists of an option granted under the company's stock incentive plan as amended and restated.
The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.
/s/ S. Scott Lieberman, Attorney-in-fact
2018-11-29